Showing results (1-10 of 377) with videos related to
Sort By:
Pageof 38
Best Practice & Research. Clinical Haematology|March 25, 2021
Immune checkpoint inhibitors in acute myeloid leukemiaNaval DaverAdvances in Experimental Medicine and Biology|January 1, 2022
An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!Fadi Haddad, Naval DaverThe American Journal of Managed Care|August 23, 2018
Unmet clinical needs and economic burden of disease in the treatment landscape of acute myeloid leukemiaMegan Wiese, Naval DaverDrugs|June 22, 2019
From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid LeukemiaMusa Yilmaz, Naval DaverHematology (Amsterdam, Netherlands)|April 18, 2012
Molecular targeted therapy in acute myeloid leukemiaNaval Daver, Jorge CortesCurrent Hematologic Malignancy Reports|March 30, 2013
Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodiesNaval Daver, Susan O'BrienThe American Journal of Managed Care|August 23, 2018
Current and emerging therapies for patients with acute myeloid leukemia: a focus on MCL-1 and the CDK9 pathwayLindsey Lyle, Naval DaverBlood Cancer Journal|May 28, 2021
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithmNaval Daver, Sangeetha Venugopal, Farhad RavandiCurrent Opinion in Hematology|January 11, 2017
'JAK-ing' up the treatment of primary myelofibrosis: building better combination strategiesRita Assi, Srdan Verstovsek, Naval DaverCurrent Hematologic Malignancy Reports|February 25, 2021
An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid LeukemiaSangeetha Venugopal, Naval Daver, Farhad RavandiPageof 38